1. Home
  2. PTGX vs TFSL Comparison

PTGX vs TFSL Comparison

Compare PTGX & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • TFSL
  • Stock Information
  • Founded
  • PTGX 2006
  • TFSL 1938
  • Country
  • PTGX United States
  • TFSL United States
  • Employees
  • PTGX N/A
  • TFSL N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • TFSL Savings Institutions
  • Sector
  • PTGX Health Care
  • TFSL Finance
  • Exchange
  • PTGX Nasdaq
  • TFSL Nasdaq
  • Market Cap
  • PTGX 5.0B
  • TFSL 3.7B
  • IPO Year
  • PTGX 2016
  • TFSL 2007
  • Fundamental
  • Price
  • PTGX $83.89
  • TFSL $13.91
  • Analyst Decision
  • PTGX Strong Buy
  • TFSL Hold
  • Analyst Count
  • PTGX 9
  • TFSL 1
  • Target Price
  • PTGX $86.22
  • TFSL $15.00
  • AVG Volume (30 Days)
  • PTGX 998.7K
  • TFSL 452.0K
  • Earning Date
  • PTGX 11-06-2025
  • TFSL 10-30-2025
  • Dividend Yield
  • PTGX N/A
  • TFSL 8.13%
  • EPS Growth
  • PTGX N/A
  • TFSL 14.29
  • EPS
  • PTGX 0.72
  • TFSL 0.32
  • Revenue
  • PTGX $209,217,000.00
  • TFSL $318,974,000.00
  • Revenue This Year
  • PTGX N/A
  • TFSL $10.29
  • Revenue Next Year
  • PTGX $140.23
  • TFSL $3.28
  • P/E Ratio
  • PTGX $115.56
  • TFSL $43.44
  • Revenue Growth
  • PTGX N/A
  • TFSL 4.70
  • 52 Week Low
  • PTGX $33.31
  • TFSL $11.29
  • 52 Week High
  • PTGX $93.25
  • TFSL $15.00
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 68.79
  • TFSL 58.99
  • Support Level
  • PTGX $76.70
  • TFSL $13.50
  • Resistance Level
  • PTGX $80.43
  • TFSL $13.80
  • Average True Range (ATR)
  • PTGX 2.82
  • TFSL 0.30
  • MACD
  • PTGX 0.11
  • TFSL 0.05
  • Stochastic Oscillator
  • PTGX 98.00
  • TFSL 96.73

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

Share on Social Networks: